Evelyn Salvaris

2.3k total citations
61 papers, 1.9k citations indexed

About

Evelyn Salvaris is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Evelyn Salvaris has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 24 papers in Genetics and 20 papers in Molecular Biology. Recurrent topics in Evelyn Salvaris's work include Xenotransplantation and immune response (34 papers), Animal Genetics and Reproduction (13 papers) and Pancreatic function and diabetes (12 papers). Evelyn Salvaris is often cited by papers focused on Xenotransplantation and immune response (34 papers), Animal Genetics and Reproduction (13 papers) and Pancreatic function and diabetes (12 papers). Evelyn Salvaris collaborates with scholars based in Australia, United States and France. Evelyn Salvaris's co-authors include Peter J. Cowan, Andy Boyd, Ian P. Wicks, Nella Fisicaro, David M. Wilkinson, Anthony J.F. d’Apice, Mark B. Nottle, J Novotný, Martin J. Pearse and Trixie A. Shinkel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Evelyn Salvaris

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evelyn Salvaris Australia 24 1.0k 569 553 343 166 61 1.9k
Éva Korpos Germany 19 257 0.3× 458 0.8× 200 0.4× 341 1.0× 84 0.5× 35 1.4k
Louis K. Birinyi United States 13 438 0.4× 593 1.0× 163 0.3× 502 1.5× 52 0.3× 19 1.6k
Manuela Gavina Italy 17 470 0.5× 1.0k 1.8× 133 0.2× 444 1.3× 100 0.6× 20 2.1k
Marion C. Dickson United Kingdom 24 205 0.2× 1.2k 2.1× 287 0.5× 415 1.2× 62 0.4× 34 2.4k
Anil Karihaloo United States 23 432 0.4× 1.2k 2.0× 638 1.2× 106 0.3× 79 0.5× 38 2.0k
Alexander Sandra United States 19 277 0.3× 832 1.5× 221 0.4× 130 0.4× 48 0.3× 38 1.5k
Alessia Mercalli Italy 26 1.1k 1.1× 593 1.0× 585 1.1× 568 1.7× 33 0.2× 47 2.4k
Valeria Sordi Italy 27 1.3k 1.3× 948 1.7× 659 1.2× 456 1.3× 40 0.2× 76 2.8k
Ofelia M. Martínez-Estrada Spain 18 337 0.3× 1.2k 2.2× 104 0.2× 156 0.5× 73 0.4× 28 2.3k
Deepa Bhartiya India 32 453 0.4× 1.7k 3.0× 413 0.7× 291 0.8× 35 0.2× 121 2.9k

Countries citing papers authored by Evelyn Salvaris

Since Specialization
Citations

This map shows the geographic impact of Evelyn Salvaris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Salvaris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Salvaris more than expected).

Fields of papers citing papers by Evelyn Salvaris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyn Salvaris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Salvaris. The network helps show where Evelyn Salvaris may publish in the future.

Co-authorship network of co-authors of Evelyn Salvaris

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Salvaris. A scholar is included among the top collaborators of Evelyn Salvaris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Salvaris. Evelyn Salvaris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pefanis, Aspasia, Anjan K. Bongoni, Jennifer L. McRae, et al.. (2024). Inhibition of RIPK1 or RIPK3 kinase activity post ischemia-reperfusion reduces the development of chronic kidney injury. Biochemical Journal. 482(2). 73–86. 5 indexed citations
2.
Salvaris, Evelyn, Nella Fisicaro, Erin Fuller, et al.. (2023). Characterisation of transgenic pigs expressing a human T cell‐depleting anti‐CD2 monoclonal antibody. Xenotransplantation. 31(1). e12836–e12836. 7 indexed citations
3.
Bongoni, Anjan K., Ingela B. Vikstrom, Jennifer L. McRae, et al.. (2021). A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia–reperfusion injury. Scientific Reports. 11(1). 21873–21873. 11 indexed citations
4.
Nordling, Sofia, Johan Brännström, Fredrik Carlsson, et al.. (2018). Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse. Scientific Reports. 8(1). 5220–5220. 19 indexed citations
5.
Nottle, Mark B., Evelyn Salvaris, Nella Fisicaro, et al.. (2017). Targeted insertion of an anti-CD2 monoclonal antibody transgene into the GGTA1 locus in pigs using FokI-dCas9. Scientific Reports. 7(1). 8383–8383. 34 indexed citations
6.
Holien, Jessica K., Veena Roberts, Evelyn Salvaris, et al.. (2017). AMP and adenosine are both ligands for adenosine 2B receptor signaling. Bioorganic & Medicinal Chemistry Letters. 28(2). 202–206. 10 indexed citations
7.
Gock, Hilton, et al.. (2016). Human Endothelial Protein C Receptor Overexpression Protects Intraportal Islet Grafts in Mice. Transplantation Proceedings. 48(6). 2200–2207. 3 indexed citations
8.
Stewart, John, Alice F. Tarantal, Wayne J. Hawthorne, et al.. (2015). Clonidine inhibits anti‐non‐Gal IgM xenoantibody elicited in multiple pig‐to‐primate models. Xenotransplantation. 22(6). 413–426.
9.
Hawthorne, Wayne J., Evelyn Salvaris, Peta Phillips, et al.. (2014). Control of IBMIR in Neonatal Porcine Islet Xenotransplantation in Baboons. American Journal of Transplantation. 14(6). 1300–1309. 76 indexed citations
10.
Stewart, John, Alice F. Tarantal, Yan Chen, et al.. (2014). Anti‐non‐Gal‐specific combination treatment with an anti‐idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response. Xenotransplantation. 21(3). 254–266. 2 indexed citations
11.
Crikis, Sandra, Xiaomin Zhang, Karen M. Dwyer, et al.. (2010). Antiinflammatory and Anticoagulant Effects of Transgenic Expression of Human Thrombomodulin in Mice. American Journal of Transplantation. 10(2). 242–250. 32 indexed citations
12.
Gock, Hilton, Lisa Murray‐Segal, Evelyn Salvaris, et al.. (2006). Cardiac and Skin Xenograft Survival in Different Recipient Mouse Strains. Transplantation. 82(10). 1362–1369. 3 indexed citations
13.
Gock, Hilton, et al.. (2004). Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting gal-mediated skin graft rejection1. Transplantation. 77(5). 751–753. 21 indexed citations
14.
Chandra, Abhilash P., Evelyn Salvaris, Stacey N. Walters, et al.. (2004). Fate of αGal +/+ pancreatic islet grafts after transplantation into αGal knockout mice. Xenotransplantation. 11(4). 323–331. 9 indexed citations
15.
Gock, Hilton, et al.. (2002). gal mismatch alone causes skin graft rejection in mice1. Transplantation. 74(5). 637–645. 11 indexed citations
16.
Salvaris, Evelyn, Hilton Gock, Wenruo Han, et al.. (2000). Naturally acquired anti‐αGal antibodies in a murine allograft model similar to delayed xenograft rejection. Xenotransplantation. 7(1). 42–47. 11 indexed citations
17.
Gock, Hilton, Evelyn Salvaris, Lisa Murray‐Segal, et al.. (2000). Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Xenotransplantation. 7(4). 237–246. 15 indexed citations
18.
Nottle, Mark B., Paul J. Verma, Christopher G. Grupen, et al.. (1999). Production of pigs expressing multiple transgenes for use in xenotransplantation studies. Theriogenology. 51(1). 422–422. 4 indexed citations
20.
Salvaris, Evelyn, et al.. (1992). Characterization of two novel pre-B-cell lines (LK63 and LiLa-1): Potential models of pre-B-cell differentiation. Leukemia Research. 16(6-7). 655–663. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026